News
Google News
Help
Help
Privacy
Terms
About Google
Get the Android app
Get the iOS app
Send feedback
Settings
Settings
Language & region
English (United States)
Sign in
Home
For you
Following
News Showcase
U.S.
World
Local
Business
Technology
Entertainment
Sports
Science
Health
More
News
Google News
Full Coverage
Sort
By relevance
By date
Share
Esperion Therapeutics to go private in buyout by Archimed
Top news
Esperion Therapeutics, Inc.
Esperion to be Acquired by ARCHIMED
6 hours ago
Save for later
Share
More
Reuters
Archimed to take Esperion Therapeutics private in $1.1 billion deal
3 hours ago
Save for later
Share
More
Fierce Pharma
Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
2 hours ago
By Fraiser Kansteiner
Save for later
Share
More
All coverage
Morningstar
Shareholder Alert: Ademi LLP investigates whether Esperion Therapeutics, Inc. is obtaining a Fair Price for Public Shareholders
2 hours ago
Save for later
Share
More
timothysykes.com
ESPR Stock In Focus As Royalty Deal Fuels Corstasis Acquisition
4 hours ago
Save for later
Share
More
qz.com
ARCHIMED to acquire Esperion Therapeutics in $1.1 billion deal
2 hours ago
By Colleen Cabili
Save for later
Share
More
Crain's Detroit Business
Ann Arbor drugmaker to be acquired by French investor
2 hours ago
By Dustin Walsh
Save for later
Share
More
The Joplin Globe
ESPR Stock Alert: Halper Sadeh LLC is Investigating Whether Esperion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
3 hours ago
Save for later
Share
More
Stocktwits
Why Did ESPR Stock Surge 58% In Pre-Market Today?
4 hours ago
By Arnab Paul
Save for later
Share
More
Investing.com
H.C. Wainwright cuts Esperion stock rating on Archimed buyout
2 hours ago
Save for later
Share
More
StocksToTrade
ESPR Rallies As Royalty Deal Fuels Corstasis Expansion
3 hours ago
By Tim Bohen
Save for later
Share
More
pehub.com
ArchiMed to take Esperion Therapeutics private for $1.1bn
8 hours ago
By Iris Dorbian
Save for later
Share
More
FirstWord Pharma
Esperion going private in $1.1B deal with investment firm
12 hours ago
Save for later
Share
More
marketscreener.com
Archimed to take Esperion Therapeutics private for up to $1.1 billion
6 hours ago
Save for later
Share
More
Benzinga
Esperion Stock Pops On Billion-Dollar ARCHIMED Buyout
5 hours ago
By Nabaparna Bhattacharya
Save for later
Share
More
WTVB
Archimed to take Esperion Therapeutics private in $1.1 billion deal
4 hours ago
Save for later
Share
More
TipRanks
Esperion agrees to $1.1 billion ARCHIMED buyout
50 minutes ago
Save for later
Share
More
Stock Titan
ARCHIMED to buy Esperion (Nasdaq: ESPR) for $3.16 per share plus CVRs
5 hours ago
Save for later
Share
More
marketscreener.com
An unknown funds, managed by ArchiMed SAS entered into a definitive agreement to acquire Esperion Therapeutics, Inc..
3 hours ago
Save for later
Share
More
Investing.com India
Archimed to acquire Esperion Therapeutics for $1 billion By Investing.com
3 hours ago
Save for later
Share
More
Investing.com Australia
ARCHIMED to acquire Esperion for up to $1.1 billion By Investing.com
6 hours ago
Save for later
Share
More
Investing.com
Archimed to acquire Esperion Therapeutics for $1 billion
3 hours ago
Save for later
Share
More
Investing.com Canada
Archimed to acquire Esperion Therapeutics for $1 billion By Investing.com
3 hours ago
Save for later
Share
More
marketscreener.com
Archimed to take Esperion Therapeutics private in $1.1 billion deal
6 hours ago
Save for later
Share
More
Search
Clear search
Close search
Google apps
Main menu
